摘要
目的探讨小骨窗血肿清除术治疗基底节区脑出血的临床疗效。方法选取2015年1月至2019年1月来我院接受手术治疗的80例基底节区脑出血患者。按照手术方案的不同,分为研究组(小骨窗开颅血肿清除术)和观察组(大骨瓣开颅血肿清除术)各40例。对两组患者的手术时间、术中出血量、术后并发症发生率、总住院时间、治疗前后格拉斯哥昏迷(GCS)评分进行观察。结果研究组的手术时间、术中出血量、总住院时间及术后并发症发生率明显低于观察组,差异有统计学差异(P<0.05);两组治疗后GCS评分ESS评分有统计学差异(P<0.05)。研究组术后并发症低于观察组,差异有统计学差异(P<0.05)。结论小骨窗血肿清除术治疗基底节区脑出血具有手术时间短、术中出血量少、术后并发症发生率低、总住院时间短、术后恢复快等优势,优于大骨瓣开颅血肿清除术。
Objective To explore the clinical effect of small bone window hematoma removal in the treatment of basal ganglia cerebral hemorrhage.Methods 80 patients with cerebral hemorrhage in basal ganglia were selected from January 2015 to January 2019.According to the different operative plan,the patients were divided into study group(small bone window craniotomy)and observation group(large bone flap craniotomy).The operation time,intraoperative bleeding volume,the rate of postoperative complication,total length of stay and Glasgow Coma(GCS)score before and after treatment were observed.Results The operation time,intraoperative blood loss,total hospitalization time and postoperative complications of the study group were significantly lower than those of the observation group with statistical difference(P<0.05);The GCS score and ESS score of the two groups after treatment were statistically different(P<0.05).Postoperative complications were lower in the study group than in the observation group,and the difference was statistically significant(P<0.05).Conclusion Small bone window hematoma removal is superior to large bone flap craniotomy in the treatment of basal ganglia cerebral hemorrhage,which has the advantages of short operation time,less intraoperative hemorrhage,lower postoperative complication rate,shorter total hospitalization time and quicker postoperative recovery.
作者
张安龙
梅小龙
ZHANG An-long;MEI Xiao-long(The First Affiliated Hospital of Baotou Medical College,Inner Mongolia University of Science and Technology,Baotou,Inner Mongolia 014010)
出处
《智慧健康》
2020年第25期34-36,共3页
Smart Healthcare
关键词
血肿清除术
基底节
脑出血
临床疗效
Removal of Hematomas
Basal ganglia
Cerebral hemorrhage
Clinical efficacy
作者简介
通讯作者:梅小龙
